Choose Your Country or Region

SMYD

Other Methylation Related Inhibitors

CDK ROCK Wee1 Aurora Kinase Chk PLK Antimetabolites APC MPS1 Rho Myc

SMYD2 SMYD3

Cat.No.	Product Name	Information	Product Use Citations
S6833	BCI-121	BCI-121 is a potent inhibitor of SMYD3 that impairs the proliferation of many kinds of cancer cells.	Clin Epigenetics, 2023, 15(1):92 Pharmacol Res, 2022, 177:106122
S7042	AZ505	AZ505 is a potent and selective inhibitor of SMYD2 with an IC50 of 0.12 μM.
S7575	LLY-507	LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltransferase SMYD2.	Acta Pharm Sin B, 2024, 14(2):712-728 Pharmacol Res, 2022, 177:106122 Oncol Lett, 2020, 20(5):153

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

S6833

BCI-121

BCI-121 is a potent inhibitor of SMYD3 that impairs the proliferation of many kinds of cancer cells.

Clin Epigenetics, 2023, 15(1):92

Pharmacol Res, 2022, 177:106122

S7042

AZ505

AZ505 is a potent and selective inhibitor of SMYD2 with an IC50 of 0.12 μM.

S7575

LLY-507

LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltransferase SMYD2.

Acta Pharm Sin B, 2024, 14(2):712-728

Pharmacol Res, 2022, 177:106122

Oncol Lett, 2020, 20(5):153